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Dendritic cells (DCs) are crucial for mounting allergic
airway inflammation, but it is unclear which subset of
DCs performs this task. By using CD64 and MAR-1
staining, we reliably separated CD11b+ monocyte-
derived DCs (moDCs) from conventional DCs
(cDCs) and studied antigen uptake, migration, and
presentation assays of lung and lymph node (LN)
DCs in response to inhaled house dust mite (HDM).
Mainly CD11b+ cDCs but not CD103+ cDCs induced
T helper 2 (Th2) cell immunity in HDM-specific
T cells in vitro and asthma in vivo. Studies in Flt3l/
mice, lacking all cDCs, revealed that moDCs were
also sufficient to induce Th2 cell-mediated immunity
but only when high-dose HDM was given. The main
function of moDCs was the production of proinflam-
matory chemokines and allergen presentation in
the lung during challenge. Thus, we have identified
migratory CD11b+ cDCs as the principal subset
inducing Th2 cell-mediated immunity in the LN,
whereas moDCs orchestrate allergic inflammation
in the lung.
INTRODUCTION
Allergic asthma is controlled by CD4+ T helper (Th) lymphocytes
that cause eosinophilic airway inflammation, mucus overproduc-
tion, and airway constriction. Dendritic cells (DCs) are the most
proficient antigen-presenting cells of the lung and play a crucial
role in the immune response to inhaled allergens like house
dust mite (HDM) by taking up the antigen and bringing it to the
draining mediastinal (M) LNs of the lung, where they polarize
the Th cell immune response (reviewed in Lambrecht and
Hammad, 2012). Dendritic cells are strategically located in close322 Immunity 38, 322–335, February 21, 2013 ª2013 Elsevier Inc.vicinity to airway epithelial cells that secrete cytokines as well as
endogenous danger signals that activate the local network of
DCs of the lung and promote Th2 cell-mediated immunity to
the allergen (Kool et al., 2011). The crucial role of DCs in medi-
ating Th2 cell-mediated immunity to inhaled antigens was re-
vealed in CD11c-DTR transgenic mice in which conditional
depletion of all CD11chi lung DCs abolished development of
Th2 cell-mediated immunity to HDM allergen (Hammad et al.,
2010). Dendritic cells also play a crucial role during the recall
phase of the allergic response, when primed Th2 cells return
to the effector site of the lung and control aspects of allergic
inflammation. During this stage, phenotypically mature DCs are
always seen in close proximity to effector Th cells inside areas
of peribronchial inflammation (Huh et al., 2003). Conditional
depletion of lung DCs during the recall phase of the allergic
response abolishes the salient features of asthma (van Rijt
et al., 2005, 2011).
In recent years, researchers have defined distinct DC subsets
differing in surface marker expression and development (Geiss-
mann et al., 2010). Common DC progenitors (CDPs) expressing
the hematopoietic cytokine receptor Flt3 generate preconven-
tional DCs (pre-cDCs) and plasmacytoid DCs (pDCs) (Onai
et al., 2007). Pre-cDCs develop further in the lung into two
subsets of cDCs, expressing either CD103 or CD11b integrins
and displaying unique functions (Sung et al., 2006). CD103+
DCs are specialized in cross-presentation of exogenous viral
antigen to CD8+ T cells (Desch et al., 2011; GeurtsvanKessel
et al., 2008). Conversely, CD11b+ DCs seem specialized in pre-
senting soluble antigen to CD4+ T cells and produce large
amounts of proinflammatory chemokines (Beaty et al., 2007;
del Rio et al., 2007). Meanwhile, plasmacytoid DCs are important
for controlling overt airway inflammation through induction of
regulatory T cells (de Heer et al., 2004).
It is assumed that lung cDCs derive from the circulating pre-
cDC progenitor and are closely related to lymphoid tissue
cDCs (Ginhoux et al., 2009). Some studies, however, have also
shown that circulating monocytes can give rise to lung DCs in
steady state (Jakubzick et al., 2008b; Varol et al., 2007). The
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moDCs and cDCs in Asthmacontribution of monocytes to the DC pool is by far more impor-
tant under inflammatory conditions. At times of infection or inha-
lation of allergens, barrier epithelial cells of the lung produce
proinflammatory chemokines like CCL2 and CCL7 that act on
the bone marrow to increase the release of CCR2hi monocytes
(Hammad et al., 2009; Leo´n et al., 2007; Serbina and Pamer,
2006). When these monocytes reach the airway mucosa as
part of an inflammatory response, they can upregulate major
histocompatibility complex class II (MHCII) glycoproteins and
CD11c and give rise to monocyte-derived DCs (moDCs) that
also express CD11b integrin and therefore easily contaminate
the CD11b+ cDC population (Robays et al., 2007). The precise
function ofmoDCs in lung immunity is unclear andmost probably
underestimated, because reliable identification of moDCs is
problematic. In other parts of the body, moDCs can be fully
capable of presenting antigen and priming immunity to the
same extent as cDCs, favoring Th1 cell immunity (Hohl et al.,
2009; Nakano et al., 2009; Wu¨thrich et al., 2012).
Here we have sought to clarify which subset of lung DCs is
important for presenting the clinically relevant HDM allergen at
times of first and repeated allergen inhalation. Unraveling this
division of labor between DC subsets in allergy identified
CD11b+ cDCs and moDCs as important players in the allergic
cascade that could be inhibited for therapeutic intervention.
RESULTS
Ly6C Is a Specific but InsensitiveMarker toDiscriminate
moDCs from CD11b+ cDCs in the Lung
Numerous methods have been used to identify the different
CD11c+ DC subsets of the lungs, but like in many other organs,
these fail to separate CD11b+ cDCs from CD11b+ moDCs. In
defining a gating strategy, we first gated out CD11c+MHCIIint
alveolar macrophages based on their strong autofluorescent
signal, SSChi granularity, and positive staining for the lectin
Siglec-F (Figure 1A). The remaining MHCII+CD11c+ lung DCs
were then further separated into CD103+ cDCs and CD11b+
cells (Figure 1B). Lung pDCs were identified as CD11c+
MHCIIloCD11bLy6C+mPDCA-1+ cells (Figure S1A available
online). To identify CD11b+ moDCs among the CD11b+ cDCs,
many investigators have used the monocytic Ly6C marker
(Leo´n et al., 2007), but Ly6C is expressed only temporarily
when monocytes differentiate into DCs. In our hands Ly6C
expression on lung DCs represented a continuum within
CD11b+ lung DCs, making it virtually impossible to place a cut-
off marker between positive and negative cells. We verified
whether Ly6Chi cells and Ly6Clo cells represented extremes of
the spectrum and identified moDCs and cDCs, respectively.
We used a competitive lineage tracing strategy to identify both
subsets, based on differential CCR2-dependent egress from
the bone marrow (Figure 1C). CD11b+ cDCs are derived from
pre-cDCs that leave the bone marrow in a CCR2-independent
manner. moDCs are derived from monocytes that require
CCR2 for egress from the bone marrow. We therefore generated
competitivemixedCD45.1WT andCD45.2Ccr2/BMchimeric
mice. In reconstituted mice, monocytes had a high CD45.1
WT:CD45.2 Ccr2/ ratio strongly in favor of the CD45.1 WT
origin, whereas T cells, B cells, and neutrophils in the blood
had a much lower ratio of CD45.1:CD45.2. In the lung, CD103+cDCs as well as pDCs had a low CD45.1:CD45.2 ratio similar
to neutrophils and lymphocytes, unequivocally indicating they
were of nonmonocytic origin. However, Ly6ChiCD11b+ DCs
had a CD45.1:CD45.2 ratio similar to blood monocytes, reliably
identifying these cells as monocyte-derived cells and validating
the usefulness of Ly6C as a specific moDC marker. Ly6Clo
CD11b+ DCs were found to have an intermediate CD45.1:
CD45.2 ratio, signifying contamination of the Ly6CloCD11b+
gate with monocyte-derived cells. Therefore, Ly6C staining
underestimates the amount of monocyte-derived cells within
the CD11b+ DC population and is a poorly sensitive method to
identify moDCs.
CD64 and MAR-1 Staining Discriminates All Monocyte-
Derived DCs from CD11b+ Conventional DCs
We next sought to find a more complete separation strategy of
CD11b+ DCs. A subset of lung DCs found in inflammatory lung
lesions after HDM exposure or viral infection can be stained
with the MAR-1 antibody, directed against the high-affinity IgE
receptor FcεRIa chain, although it was not shown whether
MAR-1 staining was able to identify moDCs exclusively or was
also upregulated on cDCs in inflammatory sites (Grayson et al.,
2007). MAR-1+CD11b+ DCs had a CD45.1 WT:CD45.2 Ccr2/
ratio comparable to that of blood monocytes, validating the
use of MAR-1 as a specific moDC marker among CD11b+
DCs. Very similar to the use of Ly6C, however, MAR-1loCD11b+
DCs displayed an intermediate mixed chimeric ratio, again indic-
ative of contamination with moDCs. moDCs recovered from the
muscle upon intramuscular vaccination or from the colitic intes-
tine express high amounts of the high-affinity IgG receptor
FcgR1(CD64) (Langlet et al., 2012; Tamoutounour et al., 2012).
With a combined staining protocol for MAR-1 and CD64,
double-positive CD11b+ DCs displayed a chimeric ratio compa-
rable to blood monocytes. Strikingly, lung MAR-1 CD64 double-
negative CD11b+ DCs cells had a chimeric ratio comparable to
T cells and B cells, illustrating the absence of ‘‘false negative’’
moDC and indicating a proper identification of CD11b+ cDCs
with this gating strategy. With CD64 and MAR1 markers as the
gold standard to identify moDCs, we found that the use of
Ly6C or MAR1 as binary markers had a sensitivity of only 57%
and 51%, respectively (Figure 1C).
Ly6C+Monocytes Develop into CD64+MAR-1+ DCs in the
Lungs of HDM-Exposed Mice
To valididate our gating strategy in the lung of inflamed mice, we
transferred 2 3 106 carboxyfluorescein diacetate succinimidyl
ester (CFSE)-labeled Ly6Chi monocytes into monopenicCcr2/
mice exposed to HDM allergen. CFSE+ cells could be readily
identified within the lung CD11c+MHCII+ DC gate and these cells
displayed a CD11b+MAR-1+CD64+ phenotype almost exclu-
sively, validating the sensitivity and specificity of our gating
approach (Figure 1D). The CFSE+ DCs expressed an interme-
diate amount of Ly6C, indicative of downregulation of Ly6C as
monocytes become moDCs. This downregulation of Ly6C
explains the high rate of false-negative moDCs when Ly6C is
used as the discriminator for moDCs.
As shown in Figure 1E, steady-state lungs contained only
a small population of moDCs within the CD11b+MHCII+CD11c+
gate. However, intratracheal (i.t.) administration of a high doseImmunity 38, 322–335, February 21, 2013 ª2013 Elsevier Inc. 323
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Figure 1. A Combination of MAR-1 and CD64 Expression Allows the Proper Identification of cDCs and moDCs in HDM-Exposed Lungs
(A) Gating strategy for lung cell populations in mice administered 100 mg HDM i.t.
(legend continued on next page)
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moDCs and cDCs in Asthmaof HDM (i.e., 100 mg) induced a massive increase in this
moDC population (Figure 1E). Tracking over time of the distinct
DC subsets upon exposure to a high dose of HDM revealed
a massive but temporary expansion of moDCs in the lungs,
with a peak occurring 3 days after exposure (Figure 1F).
pDCs and CD103+ cDCs were hardly affected by HDM
exposure.
Accumulation of DC Subsets in the Mediastinal LN
upon HDM Exposure
In the MLN, lung-derived migratory DCs can be distinguished
from LN-resident DCs because of their high expression of
MHCII and CCR7 (Figure 2A). Migratory DCs were divided
into CD103+ and CD11b+ cells and analyzed for MAR-1 and
CD64 expression (Figure 2B). While in the steady-state, only
CD103+ cDCs and CD11b+ cDCs were found in the migratory
DC gate of the MLN, HDM exposure of naive mice resulted in
the accumulation of MAR-1+ DCs in the MLN. These MAR-1+
DCs in the MLN had slightly lower expression of CD64 com-
pared with lung moDCs, yet still expressed the highest amounts
of CD64 among MLN DCs. In contrast to resident DCs, all the
migratory DC subsets expressed CCR7, although at varying
amounts (Figure 2C). Overall, cDCs had higher expression of
CCR7 compared with moDCs. As expected from their nonmi-
gratory nature, pDCs did not express CCR7 (Figure 2C) and
as such pDCs present in the MLN probably represent LN-
resident pDCs. Analysis of the CD45.1 WT:CD45.2 CCR2
ratio on different DC subsets in the MLN showed CCR2 depen-
dency of only the MAR1+CD64+ DCs and showed no increase
in the amount of false-negative moDCs in the CD11b+ cDC
gate (Figure 2D). A peak accumulation of DCs in the MLN was
observed already 1.5 days after HDM exposure, consisting
mainly of CD103+ and CD11b+ cDCs. There was a transient and
minor accumulation of moDCs in the MLN at day 3 after HDM
(Figure 2E). Overall, the area under the curve, representing the
total amount of DCs accumulating over time, was highest for
CD11b+ cDCs, followed by CD103+ cDCs, moDCs, and pDCs.
HDM Uptake and Transport by Lung DC Subsets
Because most groups that have used HDM allergen in mouse
models of asthma have used doses ranging from 1 to 100 mg
per administration for sensitization, we chose three doses within
this range to be administered i.t. and studied the antigen distri-
bution 3 days later. Most of the fluorescent HDM was taken up
by lung CD11c+ cells, including alveolar macrophages (MFs)
and DCs (Figure 3A). In the MLN, fluorescent HDM was found
almost exclusively in MHCIIhiCD11c+ cells, representing migra-
tory DCs (Figure 3B). The transport of HDM to the MLN occurred
through active cellular transport and not via passive lymphatic
drainage through a disrupted epithelial barrier as indicated by(B) Lung MHCII+CD11c+ cells are subdivided in CD103+ and CD11b+ DCs. The C
expression, or the combined MAR-1 and CD64 expression.
(C) Scatter plot graph of cell populations in the blood and lungs of chimeric mice
marrow cells. The origin of the cells was determined with the CD45.1 WT/CD45.
(D) Phenotypic analysis of CFSE+Ly6Chi monocytes transferred into Ccr2/ mic
(E) Gating strategy for pulmonary CD103+ cDCs, CD11b+CD64Mar-1 cDCs an
(F) Kinetics of CD103+ cDCs, CD11b+ cDCs, moDCs, and pDC recruitment to th
Data represent at least two (B) and three (A, C–F) independent experiments withthe fact that all accumulation of fluorescent HDM in the MLN
was abolished in Ccr7/ mice (Figure 3C). The total amount of
DC subsets as well as the total amount of HDM+ DC subsets in
the lungs (Figure 3D) and MLNs (Figure 3F) of naive mice
exposed to different doses of HDM is graphically represented
as pie charts. The percentage of DC subsets or macrophages
taking up HDM allergen in the lung and MLN is represented in
Figures 3E and 3G, respectively. Overall, CD11b+ cDCs and
moDCs took up HDM most efficiently whereas the uptake of
HDM allergen by lung CD103+ cDCs occurred only with the high-
est dose of allergen. The recruitment of moDCs was strongly
driven by allergen dose, and the few moDCs that were recruited
in response to low and intermediate doses of HDM already took
up the antigen quite efficiently. Increasing the amount of allergen
also led to progressively moremoDCs taking upHDM in the lung.
Among other APCs, macrophages became almost universally
antigen laden irrespective of dose, whereas pDCs and B cells
poorly took up HDM. In the MLN, the migratory HDM+ cells
were highly enriched for CD11b+ cDCs. Only with intermediate
and high doses of HDM did we observe a marked population
of CD103+ cDCs and moDCs that had taken up HDM. Little or
no fluorescent signal was found in LN-resident cDCs, pDCs,
and B cells (Figures 3B and 3G). Although moDCs represented
the major DC subset in the lungs upon exposure to an interme-
diate or high HDM dose, they remained the smallest DC subset
amongmigratory DCs within theMLN in all conditions, indicating
that moDCs are poorly migratory.
Th Cell Polarization in HDM-Specific T Cells Induced
by DC Subsets
To detect the induction of primary immune responses to HDM
ex vivo, we generated T cell receptor (TCR) transgenic (Tg)
mice (dubbed 1-DERb mice) recognizing an immunodominant
peptide derived from Der p 1 allergen. Naive CD62L+CD4+ cells
obtained from 1-DERb proliferated vigorously when exposed
to HDM-pulsed or Der p 1 peptide-pulsed bone marrow DCs,
and dividing T cells upregulated CD44 as a sign of effector
generation (Figure 4A). The precursor frequency of HDM-reac-
tive CD4+ T cells was calculated from CFSE profiles to vary
between 3% and 5% depending on donor, whereas in non-
Tg mice this frequency was always below 1% (data not shown).
We next studied the ex vivo potential of different APCs sorted
from the MLN or lung of HDM-exposed mice. Proliferation in
1-DERb T cells was observed only when MHCIIhiCD11chi
migratory DCs were used as APCs; no proliferation was seen
with MLN B cells or lung alveolar MFs as APCs (Figure 4B).
When migratory DCs were further subdivided, moDCs and
CD11b+ cDCs were best at inducing T cell proliferation (Fig-
ure 4C). We then measured the production of prototypic Th1
cell (IFN-g), Th17 cell (IL-17), and Th2 cell (IL-13) and regulatoryD11b+ DCs can be subdivided further on the basis of Ly6C expression, MAR-1
reconstituted with equal amounts of CD45.1+ WT and CD45.2+Ccr2/ bone
2 Ccr2/ ratio.
e.
d CD11b+CD64+Mar-1+ moDCs 3 days after PBS or HDM exposure.
e lungs of HDM-exposed mice.
three to six mice per group. *p < 0.05. See also Figure S1.
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Figure 2. A Combination of MAR-1 and CD64 Expression Discriminates between cDCs and moDCs in the MLN
(A) CCR7 expression by MHCIIhiCD11c+ migratory DCs and MHCIIintCD11c+ resident DCs in the MLNs of mice exposed to HDM.
(B) Gating strategy for CD103+ cDC, CD11b+ cDC, and CD11b+CD64+Mar-1+ mo-DC populations in the MLN of PBS- or HDM-exposed mice.
(C) CCR7 expression by different DC subsets. Mig-DCs were subdivided into CD103+ cDCs (CD103+CD11bMAR-1CD64), CD11b+ cDCs
(CD103CD11b+MAR-1CD64), and moDCs (CD103CD11b+MAR-1+CD64+) and their CCR7 expression was compared to pDCs (CD103CD11bLy-6C+
mPDCA-1+) and Res-DCs.
(D) Scatter plot graph showing the CD45.1 WT/CD45.2 Ccr2/ ratio for MLN populations of chimeric mice reconstituted with equal amounts of CD45.1+WT and
CD45.2+Ccr2/ bone marrow cells.
(E) Kinetics of recruitment of DC subsets to the MLNs of HDM-exposed mice.
Data represent at least two (D) or three (A–C, E) independent experiments with three to six mice per group. *p < 0.05.
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moDCs and cDCs in Asthma(IL-10) cytokines in the supernatant of these cultures (Fig-
ure 4D). CD11b+ cDCs and moDCs were most proficient in
inducing all these cytokines, with a slight bias for Th1 cell
induction by moDCs, whereas CD103+ cDCs induced no IFN-g
and low amounts of IL-17, IL-13, and IL-10. Because lung
macrophages did not induce T cell proliferation, and because
pDCs took up very little HDM allergen, we did not perform
these Th cell polarization assays with these cells as APCs.
Compared with CD103+ cDCs, CD11b+ cDCs expressed326 Immunity 38, 322–335, February 21, 2013 ª2013 Elsevier Inc.considerably higher amounts of cathepsin S, lysosomal-associ-
ated membrane protein-1 (Lamp1), and the peptide exchanger
H2DMb1, all involved in the MHCII-processing pathway. Mean-
while, moDCs expressed intermediate amounts of processing
machinery (Figure 4E). We did not obtain sufficient pDCs to
obtain cDNA from this fraction. Thus, CD11b+ cDCs and
moDCs induced the highest amount of effector cytokines in a
Th cell polarization assay, related to higher antigen-processing
capacity, in these cells.
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Figure 3. HDM Uptake and Presentation by Distinct DC Subsets during the Sensitization Phase of Allergic Airway Inflammation
(A–C) Uptake of Alexa Fluor 647 (AF647)-labeled HDM by CD11c+ cells in the lung (A) and MLNs of WT (B, C) and Ccr7/ (C) mice administered with the allergen
72 hr earlier.
(D) Pie charts depicting the relative proportion of each DC subset within the total or the AF647-HDM+MHCII+CD11c+ population in the lung of mice administered
with increasing doses of allergen.
(E) Proportion of AF647-HDM+ lung populations 72 hr after the allergen administration.
(F) Pie charts depicting the relative proportion of each DC subset within the total or the AF647-HDM+MHCII+CD11c+ population in theMLNs of mice administered
with increasing doses of allergen.
(G) Proportion of AF647-HDM+ MLN populations 72 hr after the allergen administration.
Data represent three independent experiments with three to six mice per group. Error bars represent the SEM. *p < 0.05.
Immunity
moDCs and cDCs in AsthmaCD11b+ cDCs and moDCs but Not CD103+ cDCs
Are Sufficient to Induce HDM Sensitization
To evaluate whether the HDM presentation by the distinct lung
DC subsets is sufficient to prime Th2 cell-mediated immunity
to HDM in vivo, we developed an intratracheal DC-transfer
protocol to sensitize mice to HDM (Figure 4F). The different DC
subsets were sorted ex vivo from the MLN of mice that received
100 mg of HDM allergen 3 days earlier. The high dose of HDM
ensured that all lung DC subsets were loaded with HDM and
migrated efficiently to the MLN (Figure 3F). Mice receivingCD11b+ cDCs or moDCs developed increased BAL fluid cellu-
larity and eosinophilic infiltration upon HDM aerosol rechallenge.
In contrast, negative control mice that received PBS-sensitized
CD11b+ DCs and mice that received CD103+ cDCs isolated
from the MLN of HDM-sensitized mice did not develop eosino-
philic infiltration (Figures 4G and 4I). In addition, HDM restimu-
lation of MLN cells isolated from mice sensitized by transfer of
CD11b+ cDCs or moDCs but not CD103+ cDCs induced the
production of the Th2 cell-associated cytokine IL-13, indicating
that both CD11b+ cDCs and moDCs but not CD103+ DCs areImmunity 38, 322–335, February 21, 2013 ª2013 Elsevier Inc. 327
CFSE
C
D
44
Unpulsed HDM Derp1 peptide
H
C
D
3
CFSE
CD103+ cDCs CD11b+ cDCs moDCs
Migratory DCs Macrophages B cells
G
I
C
D
3
0 102 103 104 105
0
104
105
10.5
0 102 103 104 105
0
104
105
2.4
0 102 103 104 105
0
104
105
1.4
0 102 103 104 105
0
103
104
105 14.7
0 102 103 104 105
0
103
104
105 8.19
0 102 103 104 105
0
103
104
105 12.4
cytokines
IFN-γ IL-17 IL-13 IL-10
0
100
200
300
400
500
CD103+cDC
CD11b+cDC
moDCs
control
pg
/m
l
0 102 103 104 105
0
102
103
104
105
37.5
0 102 103 104 105
0
102
103
104
105
1.82
0 102 103 104 105
0
102
103
104
105
9.77
C
DA
B
F
sort subsets
MLN
transfer
100µg HDM i.n.
5x HDM i.n.
analysis
3d
8d 2d
PBS CD11b cDC
CD103 cDC
500μm
moDC
IL-5
PB
S
CD
11
b+ c
DC
CD
10
3+ c
DC
mo
DC
0
IL-10
0
1000
2000
3000
4000
5000
6000
IL-13
0
1000
2000
3000
4000
5000
6000
IL-17
0
2000
4000
6000
IFN-γ
0
2000
4000
6000
1000
2000
3000
4000
5000
6000
1000
3000
5000
1000
3000
5000
* *
*
*
* *
*
C
yt
ok
in
es
 (p
g/
m
l)
IL12p40
0
10
20
30
40
50
60
70
IL12p35
0
10
20
30
40
50
IL23
0
2
4
6
8
10
R
el
at
iv
e 
ex
pr
es
si
on
J
K
CFSE
DC
s
Eo
sin
op
hil
s
Ne
ut
ro
ph
ils
Ly
mp
ho
cy
tes
Ma
cr
op
ha
ge
s
0
250000
500000
750000
1000000
PBS
CD11b+cDC
CD103+cDC
moDC
C
el
ls
 (#
)
* *
OX40L ICOSL
M
ax
 (%
)
0 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
moDC
CD11b+cDC
B cells
CD103+cDC
0 102 103 104 105
T1ST2
0
20
40
60
80
100
*
*
*
*
*
*
E
Lamp1
0
5
10
15
20
25
30
35
R
el
at
iv
e 
ex
pr
es
si
on
Caths
0
5
10
15
20
H2mB1
0
1
2
3
4
5
CD
10
3+ c
DC
CD
11
b+ c
DC
mo
DC
CD
10
3+ c
DC
CD
11
b+ c
DC
mo
DC
CD
10
3+ c
DC
CD
11
b+ c
DC
mo
DC
* *
PB
S
CD
11
b+ c
DC
CD
10
3+ c
DC
mo
DC PB
S
CD
11
b+ c
DC
CD
10
3+ c
DC
mo
DC PB
S
CD
11
b+ c
DC
CD
10
3+ c
DC
mo
DC PB
S
CD
11
b+ c
DC
CD
10
3+ c
DC
mo
DC
moDC
CD11b+cDC
CD103+cDC
500μm500μm
500μm
(legend on next page)
Immunity
moDCs and cDCs in Asthma
328 Immunity 38, 322–335, February 21, 2013 ª2013 Elsevier Inc.
Immunity
moDCs and cDCs in Asthmacapable of inducing a proper Th2 cell-mediated effector
response to HDM in vivo (Figure 4H). IL-5 and IL-10 were
induced mainly by the CD11b+ cDCs, whereas none of the
subsets induced measurable IL-17 in vivo.
We next questioned howCD11b+ cDCs andmoDCs promoted
Th2 cell-mediated immunity and addressed the expression of
known Th2 cell-associated skewing factors by flow cytometry
(Figure 4J). OX40L on DCs has been shown to promote Th2
cell-mediated immunity in the lung (Jember et al., 2001), and
we have observed reduced Th2 cell-mediated immunity to
HDM when mice received a blocking Ab to OX40L at the time
of priming (data not shown). Although in general the expression
of OX40L were low, these were highest on moDCs and
CD11b+ cDCs comparedwith CD103+ cDCs or reference B cells.
OX40L expression of pulmonary DCs is controlled by IL-33
(Besnard et al., 2011), and development of Th2 cell-mediated
immunity to HDM critically depends on IL-33 released from
airway epithelial cells (Willart et al., 2012). We therefore
measured the expression of T1/ST2, the receptor for IL-33,
and found that mainly CD11b+ cDCs and moDCs expressed it,
whereas CD103+ cDCs did not. ICOSL has been shown to be
involved in DC-driven Th2 cell-mediated immunity to allergens
(Lambrecht et al., 2000) but can also control respiratory toler-
ance by DCs. ICOSL was mainly expressed by CD103+ cDCs.
Although these findings offer some explanation for the potential
Th2 cell bias of ex vivo sorted HDM-exposed CD11b+ cDCs
and moDCs, they do not explain why moDCs have a slightly
higher Th1 cell-inducing bias in vitro. The predominant cytokine
driving Th1 cell development is IL-12p70. We therefore
measured themRNA expression of IL-12p40 and the rate limiting
IL-12p35 subunits of bioactive IL-12 (Figure 4K). Upon HDM
exposure in vivo, moDCs expressed the highest amounts of
IL-12p35 and intermediate amounts of IL-12p40, whereas
CD11b+ cDCs expressed intermediate amounts of IL-12p35.
moDCs also expressed the highest amounts of IL-23p19.
CD11b+ cDCs but Not CD103+ cDCs Are Necessary
for Th2 Cell-Mediated Immune Response Induction
to Low-Dose HDM Allergen
Having established that adoptive transfer of ex vivo purified
CD11b+ cDCs and moDCs was sufficient to prime Th2 cell-
mediated immunity to HDM upon adoptive transfer, we nextFigure 4. CD11b+ cDCs and moDCs Induce HDM-Specific Sensitizatio
(A) Proliferation of CFSE-labeled 1-DERb T cells cocultured for 4 days with unpu
(B) Proliferation of CFSE-labeled 1-DERb T cells cocultured for 4 days with mig
macrophages sorted from the lungs of HDM-exposed mice.
(C) Proliferation of CFSE-labeled 1-DERb T cells cocultured for 4 days with DC s
(D) Cytokine production in supernatants of CFSE-labeled 1-DERb T cells cocultu
(E) mRNA expression of Lamp1, CathS, and H2mB1 in CD103+ cDCs, CD11b+
genes and represented as relative expression compared to CD103+ cDCs (i.e., t
(F) Protocol of allergic airway induction by adoptively transferred DCs.
(G) Differential cell counts in the bronchoalveolar lavage of mice adoptively trans
(H) Cytokine production by MLN cells restimulated ex vivo for 4 days with HDM
(I) Hematoxylin-eosin staining of lung sections from mice injected with the differe
(J) Expression of ICOSL, OX40L, and T1/ST2 (IL-33R) on CD103+ cDCs, CD11b+
(K) mRNA expression of IL-12p40, IL-12p35, and IL-23p19 in CD103+ cDCs,
housekeeping genes and then represented as relative expression as compared
Data are representative of at least three (A–D, F–K) or two (E) independent experim
in which each time cells from ten mice were pooled and separated into the distinwanted to study which of these would be necessary to do so
in vivo, especially because functions of moDCs and CD11b+
cDCs were largely overlapping. To deplete cDCs while leaving
moDCs unaffected, we reasoned that Flt3l-deficient mice might
be a good model. Both CD103+ and CD11b+ cDCs derive from
a Flt3-expressing pre-cDC progenitor, whereas moDCs derive
from monocytes. In the lungs of HDM-exposed Flt3l-deficient
mice, there was indeed a strong reduction in CD103+ cDCs (Fig-
ure 5A). There were many residual CD11b+ DCs in the lungs of
allergen-exposed Flt3l/ mice, yet these universally expressed
CD64 and MAR-1, identifying them as moDCs (Figure 5B).
Flt3l/mice were sensitized and challenged with HDM allergen
(1 mg and 5 times 10 mg, respectively), as previously reported
(Willart et al., 2012). In this low-dose allergen-exposure protocol,
Flt3l/ mice displayed significantly less eosinophil, neutrophil,
and lymphocytic infiltration as compared to WT mice exposed
to the same protocol (Figure 5C). The size of the LNs in Flt3l/
mice was so small that we were unable to measure MLN Th
cell effector cytokine production in this experiment. Because
Flt3l/ mice lack both CD11b+ and CD103+ cDCs, we also set
up an additional experiment to deplete endogenous CD103+
cDCs of the lungs during HDM sensitization, employing lan-
gerin-DTR mice (Kissenpfennig et al., 2005). Lung CD103+
cDCs are universally and exclusively langerin positive, demon-
strating langerin promotor activity and leading to selective
depletion of this subset uponDT treatment (Figure 5D). As shown
in Figure 5E, depletion of CD103+ cDCs at the time of HDM
sensitization did not lead to reduction in Th2 cell-dependent
eosinophilic influx or mediastinal LN Th2 cell-associated cyto-
kine production (Figure 5F).
Contribution of Monocyte-Derived DCs to Th2
Cell-Mediated Immunity to HDM
The experiments in Flt3l/mice suggest that CD11b+ cDCs are
required for Th2 cell-mediated immunity to HDM, but adoptive
transfer studies (Figures 4G–4I) demonstrate that moDCs can
be sufficient to induce Th2 cell priming to HDM and others
have shown that Flt3l/ mice normally develop asthma to
high-dose cockroach allergen (Walzer et al., 2005). One possi-
bility would be that in the low-dose HDM-sensitization model,
moDCs do not get properly triggered to migrate to the MLN.
We therefore performed experiments in which Flt3l/ micen
lsed, HDM extracts or Der p 1 peptide.
ratory DCs and B cells sorted from the MLN of HDM-exposed mice, or with
ubsets sorted from the MLN of HDM-exposed mice.
red for 4 days with different MLN-derived DC subsets.
cDCs, and moDCs. mRNA expression was normalized against housekeeping
he lowest-expressing DC subset).
ferred with the different DC subsets on day 0 and rechallenged with HDM.
extracts.
nt DC subsets on day 0 and rechallenged with HDM.
cDCs, moDCs, and B cells from the lungs at day 3 after HDM sensitization.
CD11b+ cDCs, and moDCs. mRNA expression was first normalized against
to CD103+ cDCs (i.e., the lowest-expressing DC subset).
ents with three to six mice. PCR data are from three independent experiments
ct DC subsets. Error bars represent the SEM. *p < 0.05. See also Figure S2.
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Figure 5. CD11b+ cDCs but Not CD103+ cDCs Are Necessary during the Sensitization and the Challenge Phase of HDM-Induced Allergic
Airway Inflammation
(A) Analysis of the different DC subsets in the lungs of WT and Flt3l/ mice 3 days after HDM administration.
(B) Number of CD103+ cDCs, CD11b+ cDCs, and moDCs in the lungs of Flt3l/ and WT mice 3 days after HDM sensitization.
(C) Flt3l/ mice or WT were sensitized with 1 mg HDM and challenged with 10 mg HDM. BAL-differential cell counts were obtained 72 hr after the last HDM
challenge i.t.
(D) Langerin-DTR mice or WT mice were injected i.p. with 500 ng DT. The presence of CD103+ cDCs was evaluated in the lungs 24 hr later.
(E) Langerin-DTR or WT mice were sensitized and challenged with HDM as described in Figure 4C. BAL-differential cell counts were obtained 72 hr after the last
allergen challenge.
(F) Cytokine production by MLN cells restimulated ex vivo for 4 days with HDM.
Data are representative of at least three independent experiments with four to six mice per group. Error bars represent the SEM. *p < 0.05.
Immunity
moDCs and cDCs in Asthmawere exposed to a very high dose of 100 mg of HDM during both
sensitization and challenge, a dose shown to lead to significant
accumulation of moDCs in the MLN (Figure 3E). In this protocol,
Flt3L-deficient mice developed airway inflammation (Figure 6A)
and Th2 cell-associated cytokine production (Figure 6B) that
was comparable with WT mice, showing that moDCs are suffi-
cient to induce Th2 cell-mediated immunity to HDM even in the
absence of CD11b+ cDCs, when high dose of allergen is given.
As such, we conclude that when the allergen dose is sufficiently
high to induce migration of moDCs to the MLN, these moDCs
can effectively replace the CD11b+ cDCs for the induction of
Th2 cell responses. Conversely, this suggests that moDCs may
play a redundant role during airway inflammation when
CD11b+ cDCs are present. Unfortunately, no mice strains are
available in which moDCs can be selectively depleted with
antibodies or genetic targeting techniques. To address the
functional capacities of moDCs in HDM-driven asthma in vivo,
we therefore resorted to the use of Ccr2/ mice, in which
monocytes fail to exit the bone marrow. Previous studies have
shown that CCR2 is a predominant chemokine receptor that is330 Immunity 38, 322–335, February 21, 2013 ª2013 Elsevier Inc.responsible for recruitment of pulmonary CD11b+ DCs to the
allergen- or pathogen-exposed lung. When exposed to a large
dose of HDM allergen, Ccr2/ mice had normal numbers of
CD103+ cDCs and CD11b+ cDCs, whereas the number of
CD64+MAR1+ moDCs was reduced by at least 50% (Figure 6C).
When exposed to a high-dose allergen challenge protocol,
Ccr2/ mice developed less eosinophilic airway inflammation
compared with WT littermates, whereas the number of lympho-
cytes were identical between groups (Figure 6D), suggesting an
important role for monocyte-derived cells in allergic airway
inflammation. Indeed, the numbers of Th2 cell-priming CD11b+
cDCs were identical in these animals (Figure 6C), so the most
likely explanation would be that the effects of CCR2 deficiency
were mainly due to effects of moDC deficiency at the challenge
phase of eosinophilic airway inflammation.
We therefore set up experiments to look at the recruitment and
APC function of cDCs and moDCs during the allergen challenge
phase. Mice were first sensitized to HDM and challenged with
fluorescent HDM 10 days later. As shown in Figures 6E and 6F,
allergen challenge with 10 or 50 mg of HDM in already sensitized
Immunity
moDCs and cDCs in Asthmamice led to a strong increase in HDM+ moDCs in the lungs, and
globally the distribution pie charts of DCs taking up Ag in the lung
were very comparable to the pie charts seen in naive mice
exposed to the same dose of HDM during the sensitization
phase (compare Figures 6E and 6F with Figures 3D and 3E).
Note that the moDCs clearly represented the DC subset with
the highest HDM content within the lungs during the challenge
phase. In the MLN of sensitized and challenged mice, moDCs
and both subsets of cDCs were seen to carry HDM antigen,
but as during the sensitization phase moDCs represented
a minor DC population within the MLN (Figures 6G and 6H). As
during the sensitization phase, virtually all alveolar macrophages
were HDM positive (Figure 6F). MHCII antigen-processing
machinery was identically expressed in DCs sorted from the
challenge phase compared with the sensitization phase (data
not shown). When DC subsets were sorted from the lung during
the challenge phase and used to stimulate 1-DERb CD4+ T cells,
all three subsets were able to induce T cell division, as seen by
their CFSE dilution, indicative of antigen processing of the
HDM to immunogenic peptides (Figure 6I), yet moDCs are
slightly more proficient in doing so, most probably as a result
of the higher percentage of Ag uptake by these cells. Because
Ccr2/ mice had reduced and Flt3l/ mice had intact eosino-
philic airway inflammation in the high-dose allergen exposure
model, we finally addressed whether any of the DC subsets
would have a direct contribution by producing proinflammatory
mediators. We therefore measured the mRNA expression of
various chemokines known to influence allergic airway inflam-
mation by direct effects on Th effector cells, mononuclear cells,
or eosinophils. As shown in Figure 6J, moDCs strongly ex-
pressed various chemokines with activity on eosinophils and
monocytes (CCL24, eotaxin2; CCL2, MCP1; CCL7, MCP3;
CCL12, MCP5) as well as CCL4 and CCL9. Strikingly, CD11b+
cDCs produced hardly any chemokines. As reported before,
CD103+ cDCs were the predominant source of CCL17 (TARC)
and CCL22 (MDC) that have a potential to attract Th2 cells and
regulatory T (Treg) cells expressing CCR4. Amounts of CXCL1,
CXCL10, CCL3, CCL5, and CCL8 were all very low. moDCs
not only strongly expressed various chemokine mRNAs, they
also produced more CCL2 and CCL4 protein compared to
cDCs. At protein level, CCL22 was produced mainly by
CD103+ cDCs. The production of CCL6 protein could not be
confirmed in any DC subset (Figure 6K). Therefore, the known
bias for chemokine production within the CD11b+ lung DCs
seems to reside within the moDC fraction.
DISCUSSION
Dendritic cells of the lung are a heterogeneous population of
hematopoietic cells that can be broadly split in CD11b+ and
CD103+ subsets and derive from a common DC progenitor.
Adoptive transfer studies as well as developmental genetic
tagging studies with LysMCre reporter systems have revealed
that lung DCs in steady state can also originate frommonocytes,
and this pathway could be predominant when inflammation is
induced (Jakubzick et al., 2008a). Although there is no problem
in reliably identifying CD103+ cDCs, many groups have searched
for markers that could separate moDCs from cDCs within the
CD11b+ gate. We found a combination of two specific markers,CD64 and MAR-1, that unequivocally separate CCR2-depen-
dent moDCs from CCR2-independent CD11b+ cDCs and that
performs much better than the traditionally used Ly6C marker
in identifying all moDCs. We propose that this gating strategy
can be used also in studies addressing the developmental origin
of lung DC subsets. In support, we readdressed the presence
of cDCs in Flt3l/ mice and found that both CD103+ cDCs
and CD11b+ cDCs were totally absent from the lungs, whereas
residual CD11b+ DCs were universally CD64+MAR1+ moDCs.
One can argue that CD64 by itself might suffice to separate
both subsets of CD11b+ lung DCs. However, in moDCs
migrating to the MLNs and carrying HDM allergen, we noticed
some reduction in the intensity of CD64 staining. MAR1 staining,
however, compensated for this loss, because moDCs became
uniformly MAR1+ upon migration to the MLN. CD64 is emerging
as a universal discriminating marker for moDCs and macro-
phages, as we also described its usefulness in DC phenotyping
in the muscle, intestine, and skin and others found it to be
a marker for tissue-resident macrophages (Gautier et al., 2012).
With this gating strategy and a series of depletion and adoptive
transfer studies, we addressed which of the migratory DCs
was necessary and sufficient for inducing Th2 cell-mediated
immunity to HDM allergen. We did not address the involvement
of resident cDCs of the MLN, because all allergen accumulation
in the MLN was eliminated in CCR7-deficient mice and all
antigen-carrying DCs were CCR7 positive. Under conditions of
physiological low allergen exposure (1 mg dose), induction of
Th2 cell-mediated immunity to HDM was the exclusive function
of CD11b+ cDCs, as indicated by the fact that Flt3l/ DCs no
longer mounted Th2 cell-dependent eosinophilic airway inflam-
mation. Because Flt3l/ mice lack migratory and resident
cDCs, this conclusion could be reached only by comparison
with langerin-DTR mice, in which the subset of CD103+ cDCs
is exclusively depleted, showing no reduction in the strength of
the Th2 cell-mediated immune response. Upon adoptive transfer
to naive mice, only CD11b+ cDCs and not CD103+ cDCs were
able to induce Th2 cell-dependent eosinophilic airway inflamma-
tion. The fact that CD103+ cDCs do not induce Th2 cell-mediated
immunity to HDM is at odds with a recent paper reaching the
opposite conclusion (Nakano et al., 2012). In this work, BHX2
mice were analyzed carrying a mutation in the Irf8 gene that
leads to aberrant development of CD103+ cDCs. These mice
failed to develop asthma, leading the authors to conclude that
CD103+ cDCs were essential. However, BHX2 mice also have
amyeloproliferative syndrome that could suppress development
of allergy and have abnormal IL-12p40 production (Turcotte
et al., 2005). Also, induction of Th2 cell-mediated immunity by
purified CD103+ cDCs was read out in vitro through polyclonal
activation of T cells, which might have unraveled a weak Th2
cell response induced by CD103+ cDCs. Finally, differences in
the dose and batch of HDM used might have led to opposing
effects compared with our study.
When we increased the dose of HDM allergen and concomi-
tantly induced a stronger TLR4-dependent innate immune
response accompanied by production of the CCR2 ligand
CCL2, more moDCs were attracted to the lungs, and some of
these moDCs were able to migrate to the MLN, where they
were sufficient to prime for Th2 cell immunity. Also, when the
dose of HDMwas increased in Flt3l/mice, there was no longerImmunity 38, 322–335, February 21, 2013 ª2013 Elsevier Inc. 331
DC
s
eo
sin
op
hil
s
lym
ph
oc
yte
s
ne
utr
op
hil
s
ma
cro
ph
ag
es
0
100000
200000
300000
400000
500000
600000
700000
800000
900000
1000000 WT HDM 100_100
Flt3l-/- HDM 100_100
WT PBS
Flt3l-/- PBS
C
el
ls
 (#
)
A
1100000
IL-13
WT
0
500
1000
1500
2000
2500
3000
IL-5
WT Flt3l-/-
0
500
1000
1500
2000
2500
3000
IL-10
WT
0
500
1000
1500
2000
2500
3000
IFN−γ
WT
0
500
1000
1500
2000
2500
3000
IL-17
WT
0
500
1000
1500
2000
2500
3000
C
yt
ok
in
es
 (p
g/
m
l)
B
Eo
sin
op
hil
s
Ne
utr
op
hil
s
Ly
mp
ho
cy
tesDC
s
Ma
cro
ph
ag
es
0
100000
200000
300000
WT PBS
WT HDM 100_100
Ccr2-/- HDM 100_100
C
el
ls
 (#
)
D
PBS
HDM 10
HDM 50
CD103+cDCs
CD11b+cDCs
moDCs
E F
PBS 10µg HDM 50µg HDM
TOTAL
HDM+
TOTAL
HDM+
PBS 10µg HDM 50µg HDM
AF
M
0
25
50
75
100
G H
B c
ells
T c
ells pD
Cs
CD
10
3+ c
DC
CD
11
b+ c
DC
mo
DC
0
10
20
30
40
50
HD
M
+  c
el
ls 
(%
)
B
ce
lls
T c
ell
s
pD
Cs
CD
10
3+ c
DC
CD
11
b+ c
DC
mo
DC
0
10
20
30
40
50
J CCL2
0
5
10
15
20
R
el
at
iv
e 
ex
pr
es
si
on
CCL4
0
10
20
30
40
50
CCL6                   
0
10
20
30
40
50
CCL7
0
10
20
30
40
50
CCL8
0
200
400
600
800
1000
CCL9
0
10
20
30
40
50
60
70
CCL12
0
50
100
150
200
250
CCL17
0
10
20
30
40
50
CCL22
0
50
100
150
200
CCL24     
0
20
40
60
80
100
120
R
el
at
iv
e 
ex
pr
es
si
on
C
CD103+ cDCs
CD11b+ cDCs
MoDCs
CD
10
3+ c
DC
CD
11
b+ c
DC
mo
DC
0
50000
100000
150000
200000
250000
WT
Ccr2-/-
*
*
*
*
**
*
*
*
*
*
*
**
*
*
* *
*
*
*
*
*
0 103 104 105
0
103
104
105 0.3
0 103 104 105
0
103
104
105 11.7
0 103 104 105
0
103
104
105 10.3
0 103 104 105
0
103
104
105 14.4
+ HDM (no DCs) CD103+cDCs
CD11b+cDCs moDCs
CFSE
CFSE CFSE
CFSE
C
D
44
C
D
44
C
D
44
C
D
44
I
K
pg
/m
l
*
*
*
CCL4
0
50
100
150
200
CCL2
0
50
100
150
200
CCL6
0
50
100
150
200
CCL22
0
50
100
150
200
*
pg
/m
l
Flt3l-/- Flt3l-/- Flt3l-/- Flt3l-/-
C
el
ls
 (#
)
HD
M
+  c
el
ls 
(%
)
(legend on next page)
Immunity
moDCs and cDCs in Asthma
332 Immunity 38, 322–335, February 21, 2013 ª2013 Elsevier Inc.
Immunity
moDCs and cDCs in Asthmaany necessity for cDCs, because all features of airway inflamma-
tion were induced by residual and recruited moDCs. This dose
dependency of allergen on the relative contribution of moDCs
versus cDCs might also explain why Walzer et al. (2005) have
previously noted that Flt3l/ mice had intact features of cock-
roach-driven asthma, because they used a similarly high dose
of 100 mg of cockroach extract to elicit asthma (Walzer et al.,
2005). The finding that moDCs are able to induce Th2 cell-medi-
ated immunity when high-dose allergens are given is surprising
but not totally unexpected. Most of the papers that have
addressed the Th cell-polarizing capacity of moDCs have used
either Th1 cell-associated adjuvants (complete Freund’s adju-
vant) or strong bacterial (Listeria), parasitic (Leishmania), viral
(influenza), or fungal (Aspergillus, Histoplasma, Blastomyces)
infection models and have reached the conclusion that moDCs
induce Th1 cell-mediated immunity (Hohl et al., 2009; Leo´n
et al., 2007; Nakano et al., 2009; Wu¨thrich et al., 2012). We
also noticed that moDCs were slightly biased for higher IFN-g
induction compared with cDCs, accompanied by higher mRNA
expression of IL-12p35 and IL-12p40. However, there was a
concomitant induction of Th2 cell-associated cytokines in vitro
and in vivo. One of the arguments for Th1 cell induction by
moDCs is that plt mice, lacking CCL19 and the lymphoid form
of CCL21, are biased for Th1 cell-mediated immunity when
immunized with OVA and CFA. These mice have intact moDCs
in the nodes yet lack all CCR7-dependent migratory cDCs.
However, plt mice have also been shown to have enhanced
features of Th2 cell-mediated immunity in models of OVA-alum
driven asthma (Grinnan et al., 2006). Comparing these studies
shows that the Th cell bias of moDCs really depends on the
type of inciting pathogen and/or nature of the adjuvant, most
probably determining whether high IL-12 production is induced
or not. In support, we have shown that the lack of Th2 cell-
mediated immunity induced by OVA-alum in mice depleted of
all DCs can be reverted by adoptive transfer of monocytes,
developing into moDCs (Kool et al., 2008). In more Th2 cell-
biased infection models like Schistosoma mansoni infection,
CCR2-deficient animals, lacking monocyte egress and most
probably therefore also moDCs, have reduced features of Th2
cell-mediated immunity (Lu et al., 1998).
Upon allergen challenge of the lung in sensitized mice, all
subsets of moDCs and cDCs were recruited to the lung andFigure 6. Function of moDCs in Th2 Cell Immunity and Allergen Challe
(A) Flt3l/ orWTmice were sensitized with a high HDMdose (i.e., 100 mg of HDM)
the last HDM challenge, the BALf differential cell counts were determined.
(B) The MLNs were restimulated with HDM and cytokine production was measu
(C) Number of CD103+ cDCs, CD11b+ cDCs, and moDCs in the lungs of Ccr2/
(D) Ccr2/ mice or WT were sensitized and challenged as in (A). Differential cel
(E) Pie charts depicting the relative proportion of each DC subset within the total o
with increasing doses of allergen during the challenge phase.
(F) Proportion of AF647-HDM+ lung populations 72 hr after the allergen administ
(G) Pie charts depicting the relative proportion of each DC subset within the total o
with increasing doses of allergen during the challenge phase.
(H) Proportion of AF647-HDM+ MLN populations 72 hr after the allergen adminis
(I) Proliferation of CFSE-labeled 1-DERb T cells cocultured for 4 days with DC su
(J) mRNA expression of chemokines by lung DC subsets sorted 3 days after th
keeping genes and then represented as relative expression to the lowest-expres
(K) Chemokine production measured in supernatants of DC subsets sorted from
Data represent three (A, B, E–J) and two (C, D, K) independent experiments with th
Table S1.mainly CD11b+ cDCs and moDCs had captured the HDM
allergen in the lung. The increase in CD11b+ lung DCs has previ-
ously been reported in OVA-driven models of asthma (Robays
et al., 2007), and we now show that this is mainly due to an
increase in moDCs. CD11b+ lung DCs are a known source of
proinflammatory chemokines that could directly influence
inflammation at the target site, whereas CD103+ cDCs were
shown to be important for recruitment of Th2 cells via production
of Th2 cell-selective chemokines CCL17 and CCL22 (Ortiz-Stern
et al., 2011). By subdividing CD11b+ DCs, we found that
proinflammatory chemokine production is almost the exclusive
function of moDCs; CD11b+ cDCs hardly produce them. Many
of the chemokines produced have direct chemotactic activity
for eosinophils and effector T cells in the airways (Gonzalo
et al., 1998), which might explain why depletion of all DCs or
CD11b+ myeloid cells at times of allergen challenge (Medoff
et al., 2009) and absence of only 50% of moDCs in Ccr2/
mice has such dramatic effects on airway eosinophilia. We
also found the Th2 and Treg cell-tropic chemokines CCL17
and CCL22 to be selectively produced by CD103+ cDCs,
but we do not understand the full impact of this in our model
system, because depletion of CD103+ cDCs during challenge
did not reduce features of asthma (data not shown). Because
CD103+ cDCs represent only a minor fraction of total lung DCs
during allergen challenge, it is most likely that the majority of
the production of CCL17 and CCL22 still derives from moDCs,
which also produce CCL17 and CCL22 albeit in lower amounts.
In conclusion we unraveled an important division of labor
between DC subsets of the lung: CD11b+ cDCs are necessary
for priming Th2 cell immunity to physiological low doses of
HDM allergen by acting as APCs, whereas moDCs play
a predominant proinflammatory role in asthma, via production
of chemokines.
EXPERIMENTAL PROCEDURES
Mice
Langerin-DTR, CD45.1, CD45.2, Ccr7/, and Ccr2/ mice were bred at the
animal facility of the University of Ghent. Flt3l/ mice were provided by
M. Manz. b chain TCR Tg mice (1-DERb) specific for Der p 1 peptide were
generated as described in Supplemental Experimental Procedures. Experi-
ments were approved by the animal ethical committee of the University of
Ghent.nge Phase
, followed by five challenges of 100 mgHDM i.n. on consecutive days. 72 hr after
red in the culture supernatants.
and WT mice 3 days after administration of 100 mg of HDM.
l counts were analyzed 72 hr after the last HDM challenge.
r the AF647-HDM+MHCII+CD11c+ population in the lung of mice administered
ration.
r the AF647-HDM+MHCII+CD11c+ population in theMLNs of mice administered
tration.
bsets sorted from the lungs of mice during the challenge phase.
e last HDM challenge. mRNA expression was first normalized against house-
sing DC subset.
the lungs 3 days after the last HDM challenge and plated overnight.
ree to seven mice per group. Error bars represent the SEM. *p < 0.05. See also
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HDM (Dermatophagoidespteronyssinus extracts, Greer Laboratories) was
labeled with a AF647 labeling kit (Invitrogen) and injected i.t. dissolved in
80 ml of PBS. Analysis was performed on enzyme-digested lung andMLN cells.
To induce allergic airway inflammation, mice were sensitized i.n. with 1 mg
HDM extracts on day 1 and were subsequently challenged with 10 mg HDM
i.n. on days 7–11. 3 days after the last challenge, lungs, BAL, and MLNs
were collected. Flt3l/ and WT control mice were also sensitized and
challenged with 100 mg HDM in a high-dose model. To study the challenge
phase, mice were injected with 1 mg HDM i.n. followed after 1 week by chal-
lengewith PBS or 10 or 50 mgHDM-AF647 i.n. The CD103+ cells were depleted
with langerin-DTR C57BL/6 mice by i.p. injection of 500 ng diphtheria toxin
(Sigma-Aldrich) at day 1 and 2.
Chimeric Mice
CD45.2 C57BL/6 mice were irradiated with an 8 Gy dose. After 5 hr, 2 3 106
mixed bone marrow cells of CD45.1 C57BL/6 and CD45.2 Ccr2/mice (ratio
50/50) were injected i.v. After 8 weeks, mice were injected with 100 mgHDM i.t.
After 3 days, blood, lung, and MLN were obtained and stained as described
above.
Monocyte Transfer
Monocytes were sorted as Ly6ChiCD11b+ cells from spleen and bone marrow
from Rag/mice. After sorting, monocytes were CFSE labeled, according to
the protocol from the manufacturer (Invitrogen). In Ccr2/mice, 23 106 cells
were injected i.v., together with 100 mg HDM i.t. After 4 days, lungs were
obtained and analyzed.
T Cell Proliferation and Cytokine Production
To study proliferation of 1-DERb T cells, CD4+ T cells were cocultured with
CD103 cDCs, CD11b cDCs, or moDCs from the MLNs (5 T cells:1 DC ratio),
3 days after i.t. administration of HMD. During challenge, the 1-DERb T cells
were cocultured with CD103 cDCs, CD11b cDCs, or moDCs from the lung,
3 days after one challenge, 1 week after sensitization (5 T cells:1 DC ratio).
For experiments with HDM-specific T cells, CD4+ L-selectinhi cells were
MACS purified from 1-DERb TCR transgenic mice according to the protocol
of the manufacturer and labeled with CFSE, prior to coculture with ex vivo
sorted DC subsets. To study T cell proliferation, cells are stained after
3 days of coculture with combinations of CD3 (145-2C11), CD4 (RM4-5),
CD69 (H1,2F3), and CD44 (IM7) and CFSE profiles determined. Cytokines
were measured with commercially available ELISA kits (BD).
Adoptive Transfer
To test the capacities of CD103+ and CD11b+ DCs to induce Th2 cell sensiti-
zation, CD103+ cDCs, CD11b+ cDCs, or MAR1+CD64+ moDCs were sorted
from MLNs 3 days after the i.t. administration of 100 mg HDM, with a FACS
ARIA II flow cytometer. 30,000 cells of these PBS- or HDM-sensitized subsets
were administered i.t. into C57B/6 mice. 1 week later, mice were challenged
five consecutive days with i.n. injection of HDM (10 mg HMD dissolved in
40 ml PBS, Greer Laboratories), as described above.
Statistics
For all experiments, the difference between two groups was calculated with
the Mann-Whitney U test for unpaired data. If two or more groups were
compared, Kruskal-Wallis test was used (GraphPad Prism version 5.0; Graph-
Pad, San Diego, CA). Differences were considered significant when p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and one table and can be found with this article online at http://
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